<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_BioMarvel_WET_LAB_Results skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:BioMarvel/WET LAB/Results</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="mHeader_logo_box"><DIV class="mBtn-menu">≡</DIV></DIV><NAV id="topMenu"><DIV class="topMenuCen"><DIV class="mMenu_left fstBox"><UL><LI class="topMenuLi"><A class="menuLink">PROJECT▾</A></LI><LI><A class="submenuLink longLink" href="https://2018.igem.org/Team:BioMarvel/Project/Description" style="margin-top: 10px;">Description</A></LI><LI><A class="submenuLink longLink" href="https://2018.igem.org/Team:BioMarvel/Demonstrate">Demonstrate</A></LI><LI><A class="submenuLink longLink" href="https://2018.igem.org/Team:BioMarvel/Project/Parts">Parts</A></LI><LI><A class="submenuLink longLink" href="https://2018.igem.org/Team:BioMarvel/Project/Application">Application</A></LI></UL></DIV><DIV class="mMenu_left"><UL><LI class="topMenuLi"><A class="menuLink" style="min-width: 75px;">LAB▾　　</A></LI><LI><A class="submenuLink longLink" href="https://2018.igem.org/Team:BioMarvel/WET_LAB/Experiments" style="margin-top: 18px; line-height: 100%; margin-bottom: 8px;">Experiments&amp; Results</A></LI><LI><A class="submenuLink longLink" href="https://2018.igem.org/Team:BioMarvel/InterLab">InterLab</A></LI><LI><A class="submenuLink longLink" href="https://2018.igem.org/Team:BioMarvel/WET_LAB/Safety">Safety</A></LI></UL></DIV><DIV class="mMenu_left"><UL><LI class="topMenuLi"><A class="menuLink">HUMAN PRACTICES▾</A></LI><LI><A class="submenuLink longLink" href="https://2018.igem.org/Team:BioMarvel/Public_Engagement" style="margin-top: 10px;">Public Engagement</A></LI><LI><A class="submenuLink longLink" href="https://2018.igem.org/Team:BioMarvel/Human_Practices">Integrated Practices</A></LI></UL></DIV><DIV class="mMenu_left"><UL><LI class="topMenuLi"><A class="menuLink">NOTEBOOK▾</A></LI><LI><A class="submenuLink longLink" href="https://2018.igem.org/Team:BioMarvel/Notebook/Lab_Journal" style="margin-top: 10px;">Lab Journal</A></LI><LI><A class="submenuLink longLink" href="https://2018.igem.org/Team:BioMarvel/Notebook/Reference">References</A></LI></UL></DIV><DIV class="mMenu_left"><UL><LI class="topMenuLi"><A class="menuLink">PEOPLE▾</A></LI><LI><A class="submenuLink longLink" href="https://2018.igem.org/	Team:BioMarvel/People/Team" style="margin-top: 10px;">Team</A></LI><LI><A class="submenuLink longLink" href="https://2018.igem.org/Team:BioMarvel/Attributions">Attribution</A></LI><LI><A class="submenuLink longLink" href="https://2018.igem.org/Team:BioMarvel/Collaborations">Collaboration</A></LI></UL></DIV><DIV class="mMenu_left mMomenu"><UL><LI class="topMenuLi"><A class="menuLink" href="https://2018.igem.org/Team:BioMarvel/Achievement" style="cursor: pointer;">ACHIEVEMENT</A></LI></UL></DIV><DIV class="mMenu_left mMomenu"><UL><LI class="topMenuLi"><A class="menuLink" href="https://2018.igem.org/Team:BioMarvel/Entrepreneurship" style="cursor: pointer;">ENTREPRENEURSHIP</A></LI></UL></DIV></DIV></NAV><DIV class="mMainBox"><SECTION id="mSection"><H1>Results and Discussion</H1><P>The NTproBNP of diverse concentrations (10 ng/ml, 10 μg/ml) in PBS was applied and Figure 1 showed the results.The CV current valueswere 21.07μA, 37.65μA, at the concentrations, respectively, albeit no cyclic voltammetric responses were detected in PBS. The result indicates that the successful immobilization of antibodies onto the gold surface of the channel and oxidation peak currents attributed to the two-electron oxidation of PAP to PQI are dependent on immnoreactions and enzyme-substrate interactions.</P><P>In this study, a new strategy for effective immobilization ofantibodies and sensitivity enhancement in the development of an electrochemical biosensor is presented. The proposed strategy entails directlycoupling antibodies onto gold chip surfaces and employinggenetically engineered GBP-ProG fusion proteins as a novelcrosslinker. Experimental results demonstrated that the GBP-ProGproteins were successfully direct-immobilized onto immunochip viathe GBP domain, and simple and oriented binding of antibodiescould be achieved through the ProG portion of the layeredGBP-ProG without any additional chemical treatment. Theseresults provide a simple and effective approach for the fabricationof sensitive immunosensor. The electrochemical biosensor developedherein also could be used for monitoring heart failure patients.</P><H4 style="text-align: center;">Fig 1. CV current measurement with a variety of NTproBNP concentration</H4></SECTION></DIV><DIV id="mSection"><A class="mToTop" href="#" style="color: #203864;">▲ top</A></DIV><DIV class="mFooter"><DIV class="bBox"><DIV class="sssBox" style="height: 250px; width: 480px; margin-left: 60px; float: left;"><DIV class="snBox"><DIV><P style="text-align: center;">#iGEM   #2018  #BioMarvel  #Heart  #Biochip  #Diagnosis</P></DIV><SECTION style="clear: both;"><H3>Contact Us ! </H3><A href="mailto:IGEM2018BioMarvel@gmail.com" style="color: black;">IGEM2018BioMarvel@gmail.com</A></SECTION></DIV></DIV></DIV><DIV class="cpBox"><P style="text-align: center;">Copyright © 2018 By BioMarvel. All right reserved.</P></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>